The activity of axSpA ( BASDAI , Ankylosing Spondylitis Disease Activity Score ( ASDAS ) , erythrocyte sedimentation rate ( ESR ) , and high-sensitivity C-reactive protein ( hs-CRP ) ) was evaluated at baseline , 2 and 12 weeks ; adverse events were recorded at baseline , 2 , 6 , and 12 weeks .